...“We anticipate 4% to 6% [operational growth]. There will be a little bit of carryover from some of the COVID surges that we saw in the Asia Pacific region. Other...
Robotics and other orthopedic enabling technologies brought a crucial revenue lifeline to companies during the peak of the COVID pandemic. However, more market entrants and sustained economic pressures have changed...
...well. We’re entering flu season, and who knows what will happen with COVID and childhood respiratory disease, and how those factors will burden the health system.” John Bostjancic, SeaSpine CFO...
...growth closely reflects the pre-COVID average growth rate and outperforms our original estimate of 3.2%. “It feels like the orthopedic industry is about 95% of the way back to normalized...
...moved into 2020. However, the COVID-19 pandemic brought unprecedented disruption to the healthcare industry. More than two years later, many orthopedic segments are still clawing back to normalcy. This month’s...
...quarter despite the usually flat summer season. However, Vericel said the overall cartilage repair market declined 10% this year due to ongoing patient flow disruption from the COVID pandemic. Patient...
...launches will have greater significance and shaping procedures of the future,” said Globus CEO Dan Scavilla. After weathering the market disruption from COVID, Globus expects to sustain high single-digit growth...
...given the holiday season, but September picked up. Asia is in fast recovery in India and Japan. China recovered nicely versus quarter two, but they’re still below pre-COVID levels. We...
The immediate aftermath of the COVID-19 pandemic brought on an unprecedented market for orthopedic funding and M&A. Investors had a war chest of capital to deploy in search of disruptive,...
...Sales Split by Segment Recent Developments In early 2020 ATEC announced its intent to purchase EOS imaging, only to terminate the agreement two months later as the COVID-19 pandemic swept...